agilon health, inc. (AGL)
NYSE: AGL · Real-Time Price · USD
87.89
-4.65 (-5.02%)
At close: Aug 31, 2026, 4:00 PM EDT
87.65
-0.24 (-0.27%)
After-hours: Aug 31, 2026, 7:52 PM EDT

agilon health Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-232.22-391.35-260.15-262.6-106.55-406.49
Depreciation & Amortization
14.3514.8913.969.848.9510.48
Other Amortization
13.713.710.56.2--
Loss (Gain) From Sale of Assets
-19-143.7847.55--0.47
Asset Writedown & Restructuring Costs
36.0936.093.6---
Loss (Gain) on Equity Investments
15.781.84-11.65-16.49-10.726.94
Stock-Based Compensation
47.1149.1250.6669.528.38292.39
Other Operating Activities
-1.03-5.520.94-4.253.75-0.18
Change in Accounts Receivable
344.59344.59-74.58-460.37-204.17-149.04
Change in Accounts Payable
-85.59-85.594.6432.1165.7419.36
Change in Other Net Operating Assets
-206.03-69.53200.53418.197974.66
Operating Cash Flow
-72.26-105.76-57.78-156.2-130.81-148.16
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-12.69-13.24-13.25-15.83-15.43-6.56
Cash Acquisitions
----45.25--
Divestitures
---2.190.5-1.34
Sale (Purchase) of Intangibles
-21.03-29.87-28.03-14.99-17.24-6.86
Investment in Securities
115.15133.72194.9149.38-405.727.1
Investing Cash Flow
80.4288.61139.89-44.02-444.39-90.51

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-----100
Long-Term Debt Repaid
---3.75-5-5-119.9
Net Debt Issued (Repaid)
-3.5--3.75-5-5-19.9
Issuance of Common Stock
4.6-1.1711.8733.061,189
Repurchase of Common Stock
----200--
Other Financing Activities
-1.87-2.99----14.74
Financing Cash Flow
-0.77-2.99-2.58-193.1328.061,154

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
7.4-20.1579.53-393.35-547.14915.73

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-84.95-119.01-71.03-172.03-146.23-154.72
Free Cash Flow Growth
------
Free Cash Flow Margin
-1.44%-2.01%-1.17%-3.99%-6.12%-10.17%
Free Cash Flow Per Share
-5.11-7.19-4.32-10.52-8.96-10.37
Levered Free Cash Flow
-145.68-81.23-35.88-64.4-131.384.09
Unlevered Free Cash Flow
-141.32-77.08-32.02-60.24-128.577.94

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
6.65.664.65.83.674.82
Cash Income Tax Paid
10.581.85.45.311.82
Change in Working Capital
52.97189.47130.59-10.07-59.44-55.03
SEC Filings: 10-K · 10-Q